SCHEMBL2395928

SCHEMBL2395928

CCOC(=N)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2382452 0.97
SCHEMBL15661040 0.90 ALDH1A1 (0.43)
SCHEMBL17316900 0.90
SCHEMBL507070 0.88 ALDH1A1 (0.46)
Hydrochloric Acid SCHEMBL19718051 0.88 ALDH1A1 (0.42)
Hydrochloric Acid SCHEMBL16225518 0.88 ALDH1A1 (0.38)
Hydrochloric Acid SCHEMBL506728 0.86 ALDH1A1 (0.44)
SCHEMBL21449654 0.84 TSHR (0.37)
SCHEMBL21449393 0.84 GAA (0.31)
Hydrochloric Acid SCHEMBL21435137 0.83 GAA (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180312511-A1 SHORT-ACTING BENZODIAZEPINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2018-11-01 US claimed
EP-3363801-A1 SHORT-ACTING BENZODIAZEPINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2018-08-22 EP claimed
US-20230348432-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2023-11-02 US disclosed
US-20230348432-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2023-11-02 US disclosed
CN-114761402-A Novel heteroaryl-triazole compounds as pesticides 拜耳公司 2022-07-15 CN disclosed
US-20220073525-A1 COMPOSITIONS FOR INHIBITING UBIQUITIN SPECIFIC PROTEASE 1 FORMA THERAPEUTICS, INC. (US) 2022-03-10 US disclosed
EP-3902802-A1 COMPOSITIONS FOR INHIBITING UBIQUITIN SPECIFIC PROTEASE 1 Forma Therapeutics, Inc. (US) 2021-11-03 EP disclosed
CN-113563320-A Compound containing thiophene structure and application thereof in medicine 天津药物研究院有限公司 2021-10-29 CN disclosed
CN-113474346-A Composition for inhibiting ubiquitin-specific protease 1 福马治疗有限公司 2021-10-01 CN disclosed
US-11040968-B2 Pyridine derivative as ASK1 inhibitor and preparation method and use thereof FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD. (CN) 2021-06-22 US disclosed
WO-2021105091-A1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2021-06-03 WO disclosed
EP-1358165-A1 IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-11-05 EP disclosed
US-20030191311-A1 A 5-(imidazol-1-yl-methyl)-pyridine derivatives for treating an NMDA-receptor-mediated disease, neurodegeneration disorder caused by stroke or brain trauma, Alzheimer's disease, Parkinson's disease, Huntington's disease EVOTEC INTERNATIONAL GMBH (DE) 2003-10-09 US disclosed
US-20030187268-A1 Imidazole derivatives EVOTEC INTERNATIONAL GMBH (DE) 2003-10-02 US disclosed
US-6610723-B2 Such as 3-(3,4-dimethyl-phenyl)-5-(2-methyl-imidazol-1-yl-methyl)-pyridine having affinity to N-methyl-D-aspartate-receptor subtype selective blockers; central nervous system; learning, memory, neurodegeneration HOFFMANN-LA ROCHE INC. 2003-08-26 US disclosed
US-20020151715-A1 Imidazole derivatives EVOTEC INTERNATIONAL GMBH (DE) 2002-10-17 US disclosed
WO-2002060877-A1 IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-08 WO disclosed
US-5411980-A Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO., INC. (US) 1995-05-02 US disclosed
EP-0594605-A1 1-AZABICYCLIC COMPOUNDS, PROCESSES AND PHARMACEUTICAL COMPOSITONS CONTAINING THEM Beecham Group p.l.c. (GB) 1994-05-04 EP disclosed
WO-1991013885-A1 1-AZABICYCLIC COMPOUNDS, PROCESSES AND PHARMACEUTICAL COMPOSITONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1991-09-19 WO disclosed